Adma Biologics reported $35.66M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Adma Biologics USD 35.66M 3.94M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Novavax USD 24.94M 2.01M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Takeda JPY 486.2B 39.41B Sep/2026